RAPP Rapport Therapeutics, Inc.
NEUTRAL
Impact: 3/10
144
Form 144 — notice of proposed sale of securities
Latest settled — T+20d ⚠ clustered
RAPP ▲ +6.41% at T+20d
NEUTRAL call ✓ call won +6.41% · α vs SPY -3.02% · entry $31.29 → $33.30
Last close $38.40 (close Jun 12) · +22.72% from $31.29 entry
T+1d
+1.21%
call +1.21% · α +0.47%
$31.67
settled 3mo ago
T+5d
+7.67%
call +7.67% · α +3.73%
$33.69
settled 2mo ago
T+20d
+6.41%
call +6.41% · α -3.02%
$33.30
settled 7w ago
T+60d
—
call — · α —
—
in 10d
Price Chart
Loading chart...
Executive Summary
Cheryl Gault, an officer of Rapport Therapeutics, filed a Form 144 to propose the sale of 10,000 shares worth approximately $278,400. The shares were originally issued as founders' shares on September 5, 2024, and the sale is scheduled for March 30, 2026.
Actionable Insight
Monitor for actual execution of the sale; while this is a routine Form 144 filing, any large insider transaction could influence short-term sentiment, especially in a small-cap biotech with limited float.
Key Facts
- Cheryl Gault, an officer of Rapport Therapeutics, intends to sell 10,000 shares.
- The proposed sale is valued at $278,400 based on the current market price.
- Shares are being sold under Rule 144 and were originally issued as founders' shares on September 5, 2024.
- The sale is scheduled to occur on March 30, 2026, through Morgan Stanley Smith Barney LLC.
Financial Impact
$278,400 sale of 10,000 shares by an officer
insider ownershipshare float
Risk Factors
- Potential negative perception if the sale proceeds near earnings or clinical trial readouts
- Limited float in biotech stocks can amplify price impact if multiple insiders sell concurrently
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003074 |
| Document: 0001950047-26-003074-index.html | 0001950047-26-003074 |
| Document: 0001950047-26-003074.txt | 0001950047-26-003074 |
11 reports for RAPP
75%
Hit rate
best @ T+60▲ +24.87%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $35.19 awaiting T+5 | awaiting T+5 | — | $38.40 (+9.12%) |
|
May 27, 2026
18d ago
|
144
| $39.51 $34.90 | ▲ +11.67% | ▲ +12.88% | $38.40 (+2.81%) |
|
May 11, 2026
4w ago
|
144
| $37.24 $35.18 | ▲ +5.53% | ▲ +5.61% | $38.40 (−3.11%) |
|
May 8, 2026
5w ago
|
144
| $38.43 $35.18 | ▼ −8.46% | ▼ −8.37% | $38.40 (−0.08%) |
|
May 7, 2026
5w ago
|
144
| $38.04 $37.95 | ▼ −0.24% | ▼ −1.70% | $38.40 (+0.95%) |
|
May 7, 2026
5w ago
|
8-K
| $39.93 $38.08 | ▼ −4.63% | ▼ −6.14% | $38.40 (−3.83%) |
|
Apr 23, 2026
7w ago
|
DEFA14A
| $36.36 $33.00 | ▼ −9.24% | ▼ −10.72% | $38.40 (+5.61%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $36.78 $33.30 | ▼ −9.48% | ▼ −9.53% | $38.40 (+4.40%) |
|
Apr 1, 2026
10w ago
|
Press Release
| $31.67 $34.22 | ▲ +8.05% | ▲ +4.29% | $38.40 (+21.25%) |
|
Mar 30, 2026
10w ago
|
144
| $31.29 $33.69 | ▲ +7.67% | ▲ +3.73% | $38.40 (+22.72%) |
Showing 10 of 11
US Market Status
Market Closed — Opens in 5h 7m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access